Buradasınız

Böbrek Nakli Sonrası Kronik Diyaliz Hipotansiyonunun İyileşmesi: Olgu Sunumu

Recovery of Chronic Dialysis Hypotension After Kidney Transplantation: A Case Report

Journal Name:

Publication Year:

DOI: 
10.5262/tndt.2014.1001.14
Abstract (2. Language): 
Chronic dialysis hypotension is described as low systolic blood pressure (<100 mmHg) during interdialytic period. The presence of low predialysis systolic blood pressure, typically <110 mmHg, is signifi cantly associated with increased mortality. Kidney transplantation is the preferred model of renal replacement therapy in the treatment of end-stage renal disease (ESRD) as it improves quality of life and survival. In this article, a long-term hemodialysis (HD) patient with chronic hypotension improved after kidney transplantation is presented. A 39-year-old male patient received a deceased donor kidney transplant. The patient was on HD for 23 years. The patient had suffered from chronic persistent hypotension for the last 8 years. Blood pressure was 70/50 mmHg before dialysis and 60/40 mmHg after dialysis. In the post-transplant period, blood pressure was maintained above 110/70 mmHg by intermittent infusion of dopamine. Hypotension was improved after 24 days and dopamine was discontinued. Various etiologies may cause chronic hypotension in patients receiving long-term HD treatment. Kidney transplantation may improve survival and quality of life by correcting hypotension in these patients. Therefore kidney transplantation should not be avoided as renal replacement therapy in ESRD patients with hypotension.
Abstract (Original Language): 
Kronik diyaliz hipotansiyonu iki diyaliz arasındaki dönemde sistolik kan basıncı düşüklüğü (<100 mmHg) olarak tanımlanmaktadır. Diyaliz öncesi düşük sistolik kan basıncı varlığı (tipik olarak 110 mmHg’nın altı) artmış mortalite ile anlamlı ilişkilidir. Böbrek nakli yaşam kalitesini ve sağ kalımı iyileştirdiği için son dönem böbrek yetmezliği (SDBY) tedavisinde tercih edilen böbrek yerine koyma modelidir. Bu yazıda böbrek nakli sonrası kan basıncının normale geldiği hipotansiyonu olan uzun dönem hemodiyaliz (HD) hastası sunulmuştur. 39 yaşında erkek hastaya kadaverik böbrek nakli yapıldı. Hasta 23 yıldır HD’e girmekte idi. Kronik hipotansiyon 8 senedir devam etmekteydi. Kan basıncı diyaliz öncesi 70/50 mmHg, diyaliz sonrası ise 60/40 mm Hg civarında seyretmekteydi. Böbrek nakli sonrası erken dönemde aralıklı dopamin infüzyonu ile kan basıncının 110/70 mm Hg’nın üstünde olması sağlandı. Hipotansiyon 24 gün sonra düzeldi ve dopamin infüzyonu kesildi. Uzun dönem HD tedavisi alan hastalarda birçok farklı neden kronik hipotansiyona neden olabilir. Bu hastalarda böbrek nakli hipotansiyonu düzelterek hastanın sağkalım ve yaşam kalitesini düzeltebilir. Bu nedenle kronik hipotansiyonu olan SDBY hastalarında böbrek naklinden kaçınılmamalıdır.
66
69

REFERENCES

References: 

1. Cases A, Coll E: Chronic hypotension in the dialysis patient. J
Nephrol 2002; 15(4): 331-335
2. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE,
Golper TA, Agodoa LY, Young EW: Predialysis blood pressure and
mortality risk in a national sample of maintenance hemodialysis
patients. Am J Kidney Dis 1999; 33: 507-517
3. Nette RW, van den Dorpel MA, Krepel HP, Ie EH, van den
Meiracker AH, Poldermans D, Weimar W, Zietse R: Hypotension
during hemodialysis results from an impairment of arteriolar tone
and left ventricular function. Clin Nephrol 2005; 63(4): 276-283
4. Esforzado Armengol N, Cases Amenós A, Bono Illa M, Gaya Bertrán
J, Calls Ginesta J, Rivera Fillat F: Autonomic nervous system and
adrenergic receptors in chronic hypotensive haemodialysis patients.
Nephrol Dial Transplant 1997; 12: 939-944
5. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular
disease in chronic renal failure. J Am Soc Nephrol 1998; 9(Suppl):
S16-S236. Krivoshiev S, Vazelov E, Koteva A, Zlatarska S, Antonov S,
Kirjakov Z: Does uraemic autonomic neuropathy increase the risk
of sudden cardiac death? Nephrol Dial Transplant 1989; 4(1): 75-77
7. Tozawa M, Iseki K, Yoshi S, Fukiyama K: Blood pressure variability
is an adverse prognostic risk factor in end-stage renal disease.
Nephrol Dial Transplant 1999; 14: 1976-1981
8. Wolfe R, Ashby V, Milford E, Ojo A, Ettenger R, Agodoa L, Held
P, Port F: Comparison of mortality in all patients on dialysis,
patients on dialysis awaiting transplantation, and recipients of a fi rst
cadaveric transplant. N Engl J Med 1999; 341: 1725-1730
9. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH:
Heart rate variability during chronic hemodialysis and after renal
transplantation: Studies in patients without and with systemic
amyloidosis. J Am Soc Nephrol 1999; 10: 1972-198110. Rubinger D, Backenroth R, Sapoznikov D: Restoration of
barorefl ex function in patients with end-stage renal disease after
renal transplantation. Nephrol Dial Transplant 2009; 24: 1305-1313
11. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland
S, Kopple JD: Reverse epidemiology of hypertension and
cardiovascular death in the hemodialysis population: The 58th
annual fall conference and scientifi c sessions. Hypertension 2005;
45: 811-817
12. Li Z, Lacson E Jr, Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus
JM, Levin NW: The epidemiology of systolic blood pressure and
death risk in hemodialysis patients. Am J Kidney Dis 2006; 48: 606-
615
13. Artunç F: Reversal of cardiovascular risk factors in patients with
end-stage-renal-disease. Turk Neph Dial Transpl 2012; 21(1):10-20

Thank you for copying data from http://www.arastirmax.com